DICE Therapeutics, Inc.

CIK 1645569 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for DICE Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 202315-12G0001193125-23-216601
Aug 10, 2023EFFECT9999999995-23-002334
Aug 9, 202340001209191-23-045180
Aug 9, 202340001209191-23-045175
Aug 9, 202340001209191-23-045170
Aug 9, 202340001209191-23-045172
Aug 9, 202340001209191-23-045189
Aug 9, 202340001209191-23-045171
Aug 9, 2023S-8 POS0001193125-23-206899
Aug 9, 2023POSASR0001193125-23-206896
Aug 9, 202325-NSE0001354457-23-000569
Aug 9, 2023SC 14D9/A0001193125-23-206886
Aug 9, 2023S-8 POS0001193125-23-206902
Aug 9, 2023SC TO-T/A0001193125-23-206881
Aug 9, 202340001209191-23-045173
Aug 9, 202340001209191-23-045194
Aug 9, 202340001209191-23-045169
Aug 9, 2023SC 13D/A0001104659-23-089350
Aug 9, 20238-K0001193125-23-206894
Aug 9, 2023S-8 POS0001193125-23-206900
Aug 9, 2023POS AM0001193125-23-206895
Aug 9, 202340001209191-23-045182
Aug 9, 202340001104659-23-089351
Aug 8, 202310-Q0000950170-23-039758
Aug 3, 202340001209191-23-044546